HEADER ANTITUMOR PROTEIN 20-DEC-20 7DPN TITLE CRYSTAL STRUCTURE OF BRD2(BD1)WITH LIGAND ZB-BD-224 BOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: O27.1.1,REALLY INTERESTING NEW GENE 3 PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2, KIAA9001, RING3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ANTITUMOR; BET PROTEINS; BROMODOMAIN INHIBITOR; EPIGENETIC READERS, KEYWDS 2 ANTITUMOR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.LI,T.LU,P.CHEN,C.LUO,B.ZHOU REVDAT 2 29-NOV-23 7DPN 1 REMARK REVDAT 1 22-DEC-21 7DPN 0 JRNL AUTH Z.LI,T.LU,P.CHEN,C.LUO,B.ZGOU JRNL TITL STRUCTURE BASE DESIGN OF A NEW CHEMOTYPE OF FOUR-CYCLE JRNL TITL 2 COMPOUNDS AS BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITORS JRNL TITL 3 WITH THE SECOND BROMODOMAIN BIAS AND HIGHLY JRNL TITL 4 ANTI-INFLAMMATORY POTENCY JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.45 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.355 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 39793 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.961 REMARK 3 FREE R VALUE TEST SET COUNT : 1974 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.0000 - 4.3371 0.98 2744 155 0.1863 0.2127 REMARK 3 2 4.3371 - 3.4428 1.00 2712 164 0.1619 0.1707 REMARK 3 3 3.4428 - 3.0077 0.99 2701 146 0.1932 0.2347 REMARK 3 4 3.0077 - 2.7328 1.00 2685 159 0.1929 0.2532 REMARK 3 5 2.7328 - 2.5369 1.00 2712 134 0.1923 0.2121 REMARK 3 6 2.5369 - 2.3874 0.99 2718 124 0.1958 0.2393 REMARK 3 7 2.3874 - 2.2678 1.00 2711 132 0.2014 0.2526 REMARK 3 8 2.2678 - 2.1691 1.00 2748 121 0.1942 0.2150 REMARK 3 9 2.1691 - 2.0856 1.00 2709 124 0.1919 0.1979 REMARK 3 10 2.0856 - 2.0136 1.00 2673 134 0.1999 0.2716 REMARK 3 11 2.0136 - 1.9506 1.00 2673 152 0.2135 0.3100 REMARK 3 12 1.9506 - 1.8949 1.00 2707 154 0.2151 0.2543 REMARK 3 13 1.8949 - 1.8450 1.00 2667 138 0.2340 0.2742 REMARK 3 14 1.8450 - 1.8000 0.98 2659 137 0.2456 0.2882 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.209 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.760 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3016 REMARK 3 ANGLE : 0.904 4116 REMARK 3 CHIRALITY : 0.046 420 REMARK 3 PLANARITY : 0.005 520 REMARK 3 DIHEDRAL : 11.797 1795 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7DPN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1300019767. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39802 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 46.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.16800 REMARK 200 R SYM (I) : 0.16800 REMARK 200 FOR THE DATA SET : 99.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.79100 REMARK 200 R SYM FOR SHELL (I) : 0.79100 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2YEK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25-30% PEG MME 5000, 0.2M AMMONIUM REMARK 280 SULFATE, 0.1M MES PH 6.7, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.39200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.88900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.39200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.88900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 73 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 GLY B 73 REMARK 465 ARG B 74 REMARK 465 VAL B 75 REMARK 465 GLU B 183 REMARK 465 GLU B 184 REMARK 465 GLN B 185 REMARK 465 GLU B 186 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLN C 182 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 167 O HOH A 301 2.08 REMARK 500 O HOH B 365 O HOH B 380 2.14 REMARK 500 OE2 GLU C 170 O HOH C 201 2.14 REMARK 500 O HOH B 371 O HOH B 383 2.15 REMARK 500 O HOH A 361 O HOH A 374 2.16 REMARK 500 NE2 GLN A 80 O HOH A 302 2.17 REMARK 500 OE1 GLU A 140 O HOH A 303 2.19 REMARK 500 O HOH A 336 O HOH B 347 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 370 O HOH B 349 4545 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HFU A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HFU B 201 DBREF 7DPN A 73 194 UNP P25440 BRD2_HUMAN 73 194 DBREF 7DPN B 73 194 UNP P25440 BRD2_HUMAN 73 194 DBREF 7DPN C 73 194 UNP P25440 BRD2_HUMAN 73 194 SEQRES 1 A 122 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 2 A 122 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 3 A 122 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 4 A 122 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 5 A 122 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 6 A 122 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 7 A 122 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 8 A 122 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 9 A 122 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 10 A 122 THR ILE PRO LYS ASN SEQRES 1 B 122 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 2 B 122 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 3 B 122 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 4 B 122 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 5 B 122 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 6 B 122 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 7 B 122 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 8 B 122 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 9 B 122 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 10 B 122 THR ILE PRO LYS ASN SEQRES 1 C 122 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 2 C 122 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 3 C 122 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 4 C 122 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 5 C 122 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 6 C 122 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 7 C 122 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 8 C 122 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 9 C 122 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 10 C 122 THR ILE PRO LYS ASN HET HFU A 201 58 HET HFU B 201 58 HETNAM HFU 5-(1-NAPHTHOYL)-11-METHYL-8-((METHYLSULFONYL)METHYL)-4, HETNAM 2 HFU 5-DIHYDRO-2,3A1,5-TRIAZADIBENZO[CD,H]AZULEN-1(2H)-ONE FORMUL 4 HFU 2(C28 H23 N3 O4 S) FORMUL 6 HOH *212(H2 O) HELIX 1 AA1 THR A 76 VAL A 85 1 10 HELIX 2 AA2 VAL A 85 LYS A 92 1 8 HELIX 3 AA3 ALA A 96 ARG A 100 5 5 HELIX 4 AA4 ASP A 104 GLY A 109 1 6 HELIX 5 AA5 ASP A 112 ILE A 117 1 6 HELIX 6 AA6 ASP A 122 ASN A 132 1 11 HELIX 7 AA7 ALA A 137 ASN A 156 1 20 HELIX 8 AA8 ASP A 160 ALA A 178 1 19 HELIX 9 AA9 ASN B 77 VAL B 85 1 9 HELIX 10 AB1 VAL B 85 LYS B 92 1 8 HELIX 11 AB2 ALA B 96 ARG B 100 5 5 HELIX 12 AB3 ASP B 104 GLY B 109 1 6 HELIX 13 AB4 ASP B 112 ILE B 117 1 6 HELIX 14 AB5 ASP B 122 ASN B 132 1 11 HELIX 15 AB6 ALA B 137 ASN B 156 1 20 HELIX 16 AB7 ASP B 160 SER B 179 1 20 HELIX 17 AB8 ASN C 77 VAL C 85 1 9 HELIX 18 AB9 VAL C 85 HIS C 93 1 9 HELIX 19 AC1 ALA C 96 ARG C 100 5 5 HELIX 20 AC2 ASP C 112 ILE C 117 1 6 HELIX 21 AC3 ASP C 122 ASN C 132 1 11 HELIX 22 AC4 ALA C 137 ASN C 156 1 20 HELIX 23 AC5 ASP C 160 SER C 179 1 20 SITE 1 AC1 11 TRP A 97 PRO A 98 VAL A 103 LYS A 107 SITE 2 AC1 11 LEU A 108 LEU A 110 ASN A 156 ILE A 162 SITE 3 AC1 11 HOH A 306 HOH A 324 GLN B 94 SITE 1 AC2 11 GLN A 94 TRP B 97 PRO B 98 VAL B 103 SITE 2 AC2 11 LYS B 107 LEU B 108 ASN B 156 ILE B 162 SITE 3 AC2 11 MET B 165 HOH B 317 HOH B 320 CRYST1 114.784 55.778 68.098 90.00 94.25 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008712 0.000000 0.000647 0.00000 SCALE2 0.000000 0.017928 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014725 0.00000